AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Maydine M 1mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Delcure Life Sciences

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Maydine M 1mg/500mg Tablet SR

Diabexe Duo 1mg/500mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Diabexe Duo should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on your blood sugar response. Continuous use is vital; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Regular meals and readily available fast-acting glucose sources (e.g., sugary snacks, juice) are crucial preventative measures. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating women require medical consultation before use. Regular blood glucose monitoring and periodic blood tests (blood cell counts, liver function) are typically recommended.

Uses of Maydine M 1mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Maydine M 1mg/500mg Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Maydine M 1 mg/500 mg Sustained-Release Tablet with food.

Common Side effects of Maydine M 1mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Maydine M 1mg/500mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Maydine M 1 mg/500 mg Sustained-Release tablets should be taken with meals.

How Maydine M 1mg/500mg Tablet SR works:

Maydine M SR tablets (1 mg glimepiride/500 mg metformin) combine two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Maydine M 1 mg/500 mg Tablet SR with alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Maydine M 1 mg/500 mg Extended-Release tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Prolonged-release Maydine M 1 mg/500 mg tablets are contraindicated during lactation. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Exercise caution when administering Maydine M 1 mg/500 mg Tablet SR to individuals with impaired renal function; dosage modification may be necessary. Physician consultation is recommended. For patients exhibiting severe kidney disease, Maydine M 1 mg/500 mg Tablet SR is contraindicated. Routine monitoring of kidney function is advised during treatment.

LiverLiverCAUTION

For individuals with liver impairment, the use of Maydine M 1 mg/500 mg sustained-release tablets requires careful monitoring. Dosage modification of Maydine M 1 mg/500 mg sustained-release tablets may be necessary. Physician consultation is advised. In patients exhibiting mild to moderate hepatic dysfunction, Maydine M 1 mg/500 mg sustained-release tablets are typically initiated at a reduced dosage; however, their administration is contraindicated in cases of severe liver disease.

What if you forget to take Maydine M 1mg/500mg Tablet SR :

Should you forget to take your Maydine M 1 mg/500 mg SR tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Maydine M 1mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Treatment

FAQs on Maydine M 1mg/500mg Tablet SR

Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Maydine M 1 mg/500 mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Maydine M 1 mg/500 mg Tablet SR and seek immediate medical attention.
Maydine M 1 mg/500 mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Maydine M 1 mg/500 mg Tablet SR may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Maydine M 1 mg/500 mg Tablet SR can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 intake, at least annually, is recommended by some researchers.
Maydine M 1 mg/500 mg SR Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Maydine M 1 mg/500 mg SR tablets with alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Maydine M 1mg/500mg Table...
53
MRP 65
18% off